Q1 Earnings Estimate for DNLI Issued By HC Wainwright
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Denali Therapeutics in a report released on Friday, February 28th. HC Wainwright analyst A. Fein forecasts that the company will post earnings of ($0.69) per share for the quarter. HC Wainwright […]
